User profiles for Sivakumar Vijayaraghavalu
Sivakumar VijayaraghavaluAssoc. Prof. Dept. of Life Sciences (Zoology), Manipur Univ. & Adjunct Prof. IIT Madras, India Verified email at manipuruniv.ac.in Cited by 1522 |
3-D Tumor Model for In Vitro Evaluation of Anticancer Drugs
JL Horning, SK Sahoo, S Vijayaraghavalu… - Molecular …, 2008 - ACS Publications
The efficacy of potential anticancer drugs during preclinical development is generally tested
in vitro using cancer cells grown in monolayer; however, a significant discrepancy in their …
in vitro using cancer cells grown in monolayer; however, a significant discrepancy in their …
Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles
C Peetla, S Vijayaraghavalu, V Labhasetwar - Advanced drug delivery …, 2013 - Elsevier
In this review, we focus on the biophysics of cell membrane lipids, particularly when cancers
develop acquired drug resistance, and how biophysical changes in resistant cell membrane …
develop acquired drug resistance, and how biophysical changes in resistant cell membrane …
Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions
S Vijayaraghavalu, C Peetla, S Lu… - Molecular …, 2012 - ACS Publications
In our recent studies exploring the biophysical characteristics of resistant cell lipids, and the
role they play in drug transport, we demonstrated the difference of drug-resistant breast …
role they play in drug transport, we demonstrated the difference of drug-resistant breast …
Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids
C Peetla, R Bhave, S Vijayaraghavalu… - Molecular …, 2010 - ACS Publications
Understanding the role of lipids in drug transport is critical in cancer chemotherapy to overcome
drug resistance. In this study, we isolated lipids from doxorubicin-sensitive (MCF-7) and -…
drug resistance. In this study, we isolated lipids from doxorubicin-sensitive (MCF-7) and -…
Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of …
S Vijayaraghavalu, JK Dermawan… - Molecular …, 2013 - ACS Publications
Epigenetic alterations such as aberrant DNA methylation and histone modifications contribute
substantially to both the cause and maintenance of drug resistance. These epigenetic …
substantially to both the cause and maintenance of drug resistance. These epigenetic …
[HTML][HTML] An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
…, SS Daivasuga, SOAS Ravi, S Vijayaraghavalu… - Scientific reports, 2022 - nature.com
Indomethacin, a non-steroidal anti-inflammatory drug (NSAID), has been presented as a
broad-spectrum antiviral agent. This randomised clinical trial in a hospital setting evaluated the …
broad-spectrum antiviral agent. This randomised clinical trial in a hospital setting evaluated the …
[HTML][HTML] Near infra-red polymeric nanoparticle based optical imaging in Cancer diagnosis
…, A Zarrabi, S Muthupandian, S Vijayaraghavalu… - … of Photochemistry and …, 2019 - Elsevier
Cancer disease is a foremost health concern and top basis of death in comparison with
many diseases including cardiovascular disorders. During initial diagnosis (usually late …
many diseases including cardiovascular disorders. During initial diagnosis (usually late …
Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury
Y Gao, S Vijayaraghavalu, M Stees, BK Kwon… - Journal of controlled …, 2019 - Elsevier
In spinal cord injury (SCI), timely therapeutic intervention is critical to inhibit the post-injury
rapidly progressing degeneration of spinal cord. Towards that objective, we determined the …
rapidly progressing degeneration of spinal cord. Towards that objective, we determined the …
[HTML][HTML] Differential expression of non-coding RNAs in stem cell development and therapeutics of bone disorders
A Mishra, R Kumar, SN Mishra, S Vijayaraghavalu… - Cells, 2023 - mdpi.com
Stem cells’ self-renewal and multi-lineage differentiation are regulated by a complex
network consisting of signaling factors, chromatin regulators, transcription factors, and non-coding …
network consisting of signaling factors, chromatin regulators, transcription factors, and non-coding …
[HTML][HTML] Metabolic pathways, enzymes, and metabolites: opportunities in cancer therapy
…, A Mishra, P Gautam, Z Feroz, S Vijayaraghavalu… - Cancers, 2022 - mdpi.com
Simple Summary Deregulated cellular metabolism is one of the major hallmarks of cancer.
Cancer cells orchestrate abnormal metabolic reprogramming to satisfy high energy demands. …
Cancer cells orchestrate abnormal metabolic reprogramming to satisfy high energy demands. …